Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. - Wikidata - awgldk - TriplyDB

Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.

Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.

http://www.wikidata.org/entity/Q37605319

about

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening Is the false-positive rate in mammography in North America too high?Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.Racial differences in false-positive mammogram rates: results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST)Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.Is mammography screening history a predictor of future breast cancer risk?Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark.

P2860

Q26770123-BBFE7603-9CEF-4EF1-B1F9-443720A4253D Q30250289-649A7E77-D52F-4989-9837-D84E6FB9FA4B Q31036427-427B32C3-B94D-4665-BCB2-193C142720AF Q35855360-E8D29D8C-6AED-4A13-9121-035F73013875 Q36277707-EA370C3A-3A1B-4522-80CC-003F568D1E11 Q39094483-70C0DEE0-7DFB-4568-8BD9-4A74AE130F11 Q50567337-DB96C155-651E-46D2-B83D-44DCEE47AD94

P2860

Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.

http://www.wikidata.org/entity/Q37605319

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Mammographic screening interva ...... isk by race/ethnicity and age.

@en

Mammographic screening interva ...... isk by race/ethnicity and age.

@nl

type

label

Mammographic screening interva ...... isk by race/ethnicity and age.

@en

Mammographic screening interva ...... isk by race/ethnicity and age.

@nl

prefLabel

Mammographic screening interva ...... isk by race/ethnicity and age.

@en

Mammographic screening interva ...... isk by race/ethnicity and age.

@nl

P1433

Q37605319-BBFAD7EC-68A0-4550-84B0-91415FBFFF6D

P1476

Q37605319-DC6A5FCE-71F7-434A-ACED-D172CF2D5334

P2093

Q37605319-1824EDBF-D48C-4B11-AF9B-D3704014D536

Q37605319-33F1E589-672D-437C-A07E-D6CEB0DE4B92

Q37605319-34EF352A-5114-4906-88F4-BD13205FE126

Q37605319-493480AF-8026-417C-AD36-E3E5698A27B5

Q37605319-7956C6E2-BE89-4697-8D7D-588350E2E763

Q37605319-91F5EC40-E839-4A7B-8262-C540E9371EF2

Q37605319-9E548EB5-58A1-471F-8358-D17C18E413C7

Q37605319-FC26F4F0-B299-4C96-B20A-FD58B2B6D8FD

P2860

Q37605319-156C5746-B517-4A6C-8C64-ABA61B3F8C41

Q37605319-21CC1EB6-3033-49CB-A9E6-26A0F5734BF0

Q37605319-23A73B56-B424-4881-B7D1-C88E5DD25BF3

Q37605319-28B5953C-E1F8-47AD-B8E5-92F2371E2904

Q37605319-3530788B-FF3F-4E99-84DF-E95C027D5A19

Q37605319-36D280DE-F907-4A87-AFB4-56DFFAD69AA4

Q37605319-43E9B820-8733-425E-B11C-7934EC95A64B

Q37605319-51404472-D047-4795-BCF4-177280AF1069

Q37605319-534E52F7-C6C4-4D41-966C-583F93791412

Q37605319-5953613C-8695-48FA-8045-123FB7DCBF74

P304

Q37605319-BC5C1223-6BF7-4547-803B-F5723A429A8D

P31

Q37605319-B25793FF-BACD-464F-ACF4-5B2E22299DAC

P356

Q37605319-953D8151-533C-4BC5-83BA-23001E6BCCF9

P407

Q37605319-31A5C931-EC0C-4F11-AF78-4957A6FA792D

P433

Q37605319-2899EF9E-EDCB-48DC-BFB0-383FDD564A8C

P478

Q37605319-40F60920-A739-4E73-879C-601AA4E735F7

P50

Q37605319-B664DE46-B636-4AAB-A2BD-4D2A834A90F8

P577

Q37605319-0F90E6B5-7CE8-4090-8860-F9C5CB3A14B4

P698

Q37605319-B71CE5A0-548D-43AB-881B-1F7412179948

P932

Q37605319-7508DA8D-8FD4-4EAA-939B-4C2617C0F11D

P356

P1433

P1476

Mammographic screening interva ...... risk by race/ethnicity and age

@en

P2093

Berta Geller

http://www.w3.org/2001/XMLSchema#string

Dejana Braithwaite

http://www.w3.org/2001/XMLSchema#string

Diana L Miglioretti

http://www.w3.org/2001/XMLSchema#string

Ellen S O'Meara

http://www.w3.org/2001/XMLSchema#string

Karen J Wernli

http://www.w3.org/2001/XMLSchema#string

Karla Kerlikowske

http://www.w3.org/2001/XMLSchema#string

Kim L Dittus

http://www.w3.org/2001/XMLSchema#string

Weiwei Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for breast cancer: an update for the U.S. Preventive Services Task Force

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

Modelling the cumulative risk of a false-positive screening test.

Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study

Comparison of 1- and 2-year screening intervals for women undergoing screening mammography.

Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.

Accuracy of diagnostic mammography at facilities serving vulnerable women.

Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study.

P304

3959-3967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28310

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Rebecca Hubbard

P577

2013-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24037812

http://www.w3.org/2001/XMLSchema#string

P932

3935985

http://www.w3.org/2001/XMLSchema#string